drugset / Trial / NCT01412437
Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria
RandomizedParallel-groupOpen-labelDiagnostic
Summary
The investigators will use different types of brain imaging (MRI) in patients with Phenylketonuria (PKU) who are currently not on a strict diet to test the hypothesis that there is improvement in brain circuitry and biochemistry after return to diet and/or sapropterin dihydrochloride (Kuvan).
Timeline
- Start
- 2011-04
- Primary completion
- 2012-03
- Completion
- 2012-12
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sapropterin | Unknown | 10 mg/kg | — |
| Subject | sapropterin | Unknown | 20 mg/kg | — |